secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lifeloc Technologies, Inc (LCTC)
CIK:        0001493137
Form:       8-K
Filed at:   2026-08-14T19:43:42+00:00
Accession:  0001079973-26-001110
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifeloc Q2 2026 revenue up 10% to $2.445M, net loss narrows to $(134K)
----------------------------------------------------------------------

- Q2 2026 net revenue $2.445M, up 10% YoY; net loss $(134K) or $(0.05) diluted vs $(394K) or $(0.14) in Q2 2025.
- Six-month revenue $4.739M, loss $(287K) or $(0.10) vs $4.496M and $(686K) or $(0.25) prior year.
- Gross margin improved to 45% from 42% YoY; R&D spend $560K on SpinDetect analyzer development.
- SpinDetect oral-fluid analyzer beta testing to start; limited commercial launch targeted for Q1 2027.
- Closed $500K loan from Chairman/CFO at 10.5% interest, secured by all assets, to fund operations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1493137/000107997326001110/0001079973-26-001110-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1493137/000107997326001110/lctc_8k.htm
  HTML page:      https://secwatch.observer/filing/0001079973-26-001110

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer